Mechanism of inhibiting proliferation of hepatocellular carcinoma Hepa1‑6 cells by embryonic stem cell‑conditioned medium

Li,Longqin; Zheng,Yichao; Zheng,Qi; Jiang,Jiaji

doi:10.3892/etm.2020.8527

Mechanism of inhibiting proliferation of hepatocellular carcinoma Hepa1‑6 cells by embryonic stem cell‑conditioned medium

Authors:
- Longqin Li
- Yichao Zheng
- Qi Zheng
- Jiaji Jiang
View Affiliations

Affiliations: Liver Research Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China
Published online on: February 12, 2020 https://doi.org/10.3892/etm.2020.8527
Pages: 2406-2414
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the antiproliferative effect of embryonic stem cell‑conditioned medium (ESC‑CM) on the mouse liver cancer Hepa1‑6 cells in vitro. Furthermore, in order to elucidate the underlying molecular mechanism, the microRNAs (miRNAs) in ESC‑CM associated with the inhibition of Hepa1‑6 proliferation were identified. Following the co‑culture of ESC‑CM and Hepa1‑6 in Transwell chambers, the proliferation, cell cycle, apoptosis and associated protein expression were determined in Hepal‑6 cells. Moreover, miRNA array analysis was employed to identify differentially expressed miRNAs. Based on the differentially expressed miRNAs, the target genes and potential associated signaling pathways were determined. Finally, RT‑qPCR was conducted to confirm the above results. The ESC‑CM inhibited Hepal‑6 cell proliferation and increased the percentage of cells at G1 phase and decreased the percentage of cells at the G2/M phase of the cell cycle. The expression of cyclin D1/cyclin‑dependent kinase (CDK)4/CDK6 was decreased following co‑culture, with no effect on cell apoptosis. Six significantly regulated miRNAs were identified and 423 putative target genes of these regulated miRNAs were predicted. Gene ontology analysis revealed the putative target genes to be associated with the ‘DNA replication (GO: 0006260)’ GO term, ‘apoptosis’ and ‘signal transduction’. The Kyoto Encyclopedia of Genes and Genomes analysis indicated that deregulated miRNAs were enriched in the Wnt signaling (KEGG entry: Map 04310) and Hippo signaling pathways (KEGG entry: Map 04390), pathways associated with cancer. Overall, the present study demonstrated the inhibition of Hepa1‑6 cell line proliferation upon treatment with ESC‑CM, by decreasing cell cycle‑associated protein cyclin D1/CDK4/CDK6 expression and arresting cells in G1 phase of the cell cycle, with no effect on cell apoptosis. Furthermore, the inhibition of proliferation by ESC‑CM may be mediated by miRNAs that affect cell cycle‑associated mRNAs and the Wnt signaling pathway.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
2	Ryan MJ, Willatt J, Majdalany BS, Kielar AZ, Chong S, Ruma JA and Pandya A: Ablation techniques for primary and metastatic liver tumors. World J Hepatol. 8:191–199. 2016.PubMed/NCBI View Article : Google Scholar
3	Boroviak T, Loos R, Bertone P, Smith A and Nichols J: The ability of inner-cell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specification. Nat Cell Biol. 16:516–528. 2014.PubMed/NCBI View Article : Google Scholar
4	Williams JW III, Carlson DL, Gadson RG, Rollins-Smith L, Williams CS and Mckinnell RG: Cytogenetic analysis of triploid renal carcinoma in Rana pipiens. Cytogenet Cell Genet. 64:18–22. 1993.PubMed/NCBI View Article : Google Scholar
5	Illmensee K: Reversion of malignancy and normalized differentiation of teratocarcinoma cells in chimeric mice. Basic Life Sci. 12:3–25. 1978.PubMed/NCBI View Article : Google Scholar
6	Melzer C, von der Ohe J, Lehnert H, Ungefroren H and Hass R: Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells. Mol Cancer. 16(28)2017.PubMed/NCBI View Article : Google Scholar
7	Giuffrida D, Rogers IM, Nagy A, Calogero AE, Brown TJ and Casper RF: Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth. Cell Prolif. 42:788–798. 2009.PubMed/NCBI View Article : Google Scholar
8	Cavallari C, Fonsato V, Herrera MB, Bruno S, Tetta C and Camussi G: Role of lefty in the anti tumor activity of human adult liver stem cells. Oncogene. 32:819–826. 2013.PubMed/NCBI View Article : Google Scholar
9	He N, Feng G, Li Y, Xu Y, Xie X, Wang H, Wang Y, Ou L, Pei X and Liu N: Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer. Stem Cell Res Ther. 7(95)2016.PubMed/NCBI View Article : Google Scholar
10	Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H and Lyden D: Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis. Cancer Cell. 30:836–848. 2016.PubMed/NCBI View Article : Google Scholar
11	Gopal SK, Greening DW, Rai A, Chen M, Xu R, Shafiq A, Mathias RA, Zhu HJ and Simpson RJ: Extracellular vesicles: Their role in cancer biology and epithelial-mesenchymal transition. Biochem J. 474:21–45. 2017.PubMed/NCBI View Article : Google Scholar
12	Khan M, Nickoloff E, Abramova T, Johnson J, Verma SK, Krishnamurthy P, Mackie AR, Vaughan E, Garikipati VN, Benedict C, et al: Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 117:52–64. 2015.PubMed/NCBI View Article : Google Scholar
13	Yaddanapudi K, Mitchell RA, Putty K, Willer S, Sharma RK, Yan J, Bodduluri H and Eaton JW: Vaccination with embryonic stem cells protects against lung cancer: Is a broad-spectrum prophylactic vaccine against cancer possible? PLoS One. 7(e42289)2012.PubMed/NCBI View Article : Google Scholar
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
15	Zhang ZJ, Chen XH, Chang XH, Ye X, Li Y and Cui H: Human embryonic stem cells-a potential vaccine for ovarian cancer. Asian Pac J Cancer Prev. 13:4295–4300. 2012.PubMed/NCBI View Article : Google Scholar
16	Zhang Z, Chen X, Chang X, Ye X, Li Y and Cui H: Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer. Int J Mol Med. 31:147–153. 2013.PubMed/NCBI View Article : Google Scholar
17	Adam V, Wauters I and Vansteenkiste J: Melanoma-associated antigen-A3 vaccination in the treatment of non-small-cell lung cancer. Exp Opin Biol Ther. 14:365–376. 2014.PubMed/NCBI View Article : Google Scholar
18	Qiu ZA and He GP: MicroRNA-134 functions as a tumor suppressor gene in gastric cancer. Am J Transl Res. 8:4320–4328. 2016.PubMed/NCBI
19	Chen T, Gao F, Feng S, Yang T and Chen M: MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway. Biochem Biophys Res Commun. 464:748–754. 2015.PubMed/NCBI View Article : Google Scholar
20	Muluhngwi P, Krishna A, Vittitow SL, Napier JT, Richardson KM, Ellis M, Mott JL and Klinge CM: Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells. Cancer Lett. 388:230–238. 2017.PubMed/NCBI View Article : Google Scholar
21	Yu DS, An FM, Gong BD, Xiang XG, Lin LY, Wang H and Xie Q: The regulatory role of microRNA-1187 in TNF-α-mediated hepatocyte apoptosis in acute liver failure. Int J Mol Med. 29:663–668. 2012.PubMed/NCBI View Article : Google Scholar
22	Balakathiresan NS, Chandran R, Bhomia M, Jia M, Li H and Maheshwari RK: Serum and amygdala microRNA signatures of posttraumatic stress: Fear correlation and biomarker potential. J Psychiatr Res. 57:65–73. 2014.PubMed/NCBI View Article : Google Scholar
23	Liu LJ, Xie SX, Chen YT, Xue JL, Zhang CJ and Zhu F: Aberrant regulation of Wnt signaling in hepatocellular carcinoma. World J Gastroenterol. 22:7486–7499. 2016.PubMed/NCBI View Article : Google Scholar
24	Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, et al: Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer. 8(90)2009.PubMed/NCBI View Article : Google Scholar
25	Toyama T, Lee HC, Koga H, Wands JR and Kim M: Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res. 8:254–265. 2010.PubMed/NCBI View Article : Google Scholar
26	Pang EY, Bai AH, To KF, Sy SM, Wong NL, Lai PB, Squire JA and Wong N: Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells. Hepatology. 46:436–445. 2010.PubMed/NCBI View Article : Google Scholar
27	Shu F, Lv S, Qin Y, Ma X, Wang X, Peng X, Luo Y, Xu BE, Sun X and Wu J: Functional characterization of human PFTK1 as a cyclin-dependent kinase. Proc Natl Acad Sci USA. 104:9248–9253. 2007.PubMed/NCBI View Article : Google Scholar
28	Jiang M, Gao Y, Yang T, Zhu X and Chen J: Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett. 583:2171–2178. 2009.PubMed/NCBI View Article : Google Scholar
29	Sun T, Co NN and Wong N: PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma. Biochem Biophys Res Commun. 449:163–168. 2014.PubMed/NCBI View Article : Google Scholar
30	Wang H, Du YC, Zhou XJ, Liu H and Tang SC: The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy. Cancer Metastasis Rev. 33:173–181. 2014.PubMed/NCBI View Article : Google Scholar